Books > Business & Economics > Business & management
|
Buy Now
FDA in the Twenty-First Century - The Challenges of Regulating Drugs and New Technologies (Hardcover)
Loot Price: R2,359
Discovery Miles 23 590
|
|
FDA in the Twenty-First Century - The Challenges of Regulating Drugs and New Technologies (Hardcover)
Expected to ship within 10 - 15 working days
|
In its decades-long effort to assure the safety, efficacy, and
security of medicines and other products, the Food and Drug
Administration has struggled with issues of funding, proper
associations with industry, and the balance between consumer choice
and consumer protection. Today, these challenges are compounded by
the pressures of globalization, the introduction of novel
technologies, and fast-evolving threats to public health. With
essays by leading scholars and government and private-industry
experts, FDA in the Twenty-First Century addresses perennial and
new problems and the improvements the agency can make to better
serve the public good. The collection features essays on effective
regulation in an era of globalization, consumer empowerment, and
comparative effectiveness, as well as questions of data
transparency, conflicts of interest, industry responsibility, and
innovation policy, all with an emphasis on pharmaceuticals. The
book also intervenes in the debate over off-label drug marketing
and the proper role of the FDA before and after a drug goes on the
market. Dealing honestly and thoroughly with the FDA's successes
and failures, these essays rethink the structure, function, and
future of the agency and the effect policy innovations may have on
regulatory institutions abroad.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.